Aligos Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Aligos Therapeutics, Inc. has filed 345 SEC EDGAR filings since 16 Jan 2020

SEC filing history

Showing 251-275 of 345 matching filings.

Per page
25
Current page
11
3

FORM 3

Filing date
18 Nov 2021
Reporting date
16 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
15 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-260774

S-3

Filing date
04 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91770

SC 13G filing

Filing date
13 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39617

FORM 8-K

Filing date
05 Aug 2021
Reporting date
05 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-257466

424B4

Filing date
01 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-257466

EFFECT filing

Filing date
30 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
28 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
28 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-257466

S-1

Filing date
28 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39617

8-K

Filing date
24 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-39617

8-K/A

Filing date
24 Jun 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91770

SC 13D/A

Filing date
21 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91770

SC 13D/A

Filing date
21 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2021
Reporting date
11 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
10 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .